With an aim to provide affordable and quality medicines for all, MSN Labs is successfully running its business operations in over 16 countries of the African region. It is a wholly owned subsidiary of the MSN Group of Companies with its regional office incorporated in Nairobi, Kenya.
MSN Labs’ Nairobi, Kenya office supports functions of all the countries in the Africa region – Mauritius, Kenya, Tanzania, Malawi, Nigeria, Burundi, Ghana, Uganda, Ethiopia, Namibia, Zimbabwe, Madagascar, Zambia, Rwanda, Sudan and FWA
Medical services extended in the Africa region are in the field of:
As part of patient awareness and other major initiatives, the team is involved in:
The Africa team follows a business model of direct operations and has successfully launched the first branded generics like Lacosamide, Pulmofirst, Silodosin, Olmesartan, Fosaprepitant, etc., in most of the countries. Some of these are top brands in the market. Our major thrust areas are out-licensing and in-licensing, wherever there is scope for business synergy.
With scientific engagement and knowledge upgradation as our core strategy, our teams are actively involved in several scientific events held for the healthcare practitioners and paramedics alike. Updates related to the latest guidelines on disease management are among several other matters discussed.
The vision is to establish MSN Labs in the region as a research oriented key partner, supporting stake holders with many first to launch, quality and affordable branded generics.